No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

ANZ Journal of Surgery

Our medical research library holds 12 studies published in ANZ Journal of Surgery (2001–2021). Each entry links to the study's record on PubMed and, where there is one, to the publisher's page and a free full text. 3 have an abstract, the authors' own summary as PubMed records it: open "Abstract" to read it. For 2 studies PubMed has no abstract for, we give the abstract printed in the article or, where there is none, a summary we wrote from it, each labeled as such.

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

About the journal

  • Publisher: Wiley-Blackwell Publishing Asia
  • Published: 2001 to the present, Australia
  • Language: English
  • ISSN: 1445-1433 (print), 1445-2197 (electronic)
  • Continues: Australian and New Zealand Journal of Surgery
  • Its record in the NLM Catalog

2020s

2010s

  • Malignant mesothelioma of the tunica vaginalis: a atypical presentation of a rare scrotal tumour. M.C. Harris, C. Logan, A. Chetwood, et al. 2019;89(12):E562-E563. Case report PubMed · Publisher

  • Prostate-specific membrane antigen avidity on positron emission tomography scan in malignant pleural mesothelioma. S.K.D.M. Ekanayake, I.A. Yang, D.B. Godbolt, et al. 2019;89(9):E406-E407. Case report PubMed · Publisher

  • Benign multicystic peritoneal mesothelioma: a rare cause of intra-abdominal cystic disease. B. Campbell, D. Mehanna, J. Stone. 2017;87(6):E15-E16. Case report PubMed · Publisher

    Summary

    The authors reported a case of benign multicystic peritoneal mesothelioma (BMPM), a rare benign cystic lesion arising from the peritoneal mesothelium. About 130 cases had been reported since it was first described in 1979. A 49-year-old woman presented with abdominal pain, mainly epigastric, of 3 months' duration. The pain had become constant and was worse with eating. She also had bloating and had lost several kilograms over 6 months. Computed tomography showed a small amount of free fluid in the right hepatorenal pouch and a suggestion of a small nodular density in the greater omentum near the pylorus. Ultrasound, endoscopy, colonoscopy, blood tests and tumour markers (CEA, CA19-9, CA-125) were normal. Because her symptoms worsened, she underwent diagnostic laparoscopy. This found multiple cystic nodules on the greater omentum and a cystic nodule on the right ovary. The omental cysts were excised, and an appendicectomy and right oophorectomy were performed. Histopathology confirmed BMPM. Reviewing the literature, the authors stated that BMPM occurs most often in women of child-bearing age, has been associated with chronic irritation of the peritoneum, and has no relation to prior asbestos exposure. They described surgical resection as the treatment of choice and noted that local recurrence was possible. They concluded that wider use of diagnostic laparoscopy may increase incidental findings of BMPM, so greater awareness of the condition and its surgical treatment is needed.

    PubMed has no abstract for this study, and the article doesn't print one. We wrote this summary from the full article with the help of AI. It is not the authors' wording.

  • Iterative surgery for recurrent malignant pleural mesothelioma in long-term survivor. G. Leuzzi, E. Melis, D. Forcella, et al. 2017;87(11):946-947. Case report PubMed · Publisher

  • Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis. Y. Huang, N.A. Alzahrani, W. Liauw, et al. 2017;87(1-2):49-54. PubMed · Publisher

    Abstract

    Background: Combined cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC) has been considered as a standard approach for peritoneal surface malignancy. This study aims to assess the learning curve of this combined approach.

    Methods: Prospectively collected data of our first 800 consecutive patients treated by CRS and PIC between January 1996 and July 2014 were retrospectively reviewed. Eight hundred patients were divided into two groups and eight groups for comparison. A significant difference was defined as P < 0.05.

    Results: A significant increase in the rate of the completeness of cytoreduction (CC) score-0 from 74.0% to 83.0% was seen with a reduction in rates of other CC scores. Also, there was a decreasing trend in mean blood transfusion units. The rate of viscus perforation, fistula formation and small bowel obstruction was significantly lower in the recent 400 patients. However, there was a significant increase in the incidence of deep venous thrombosis and pulmonary embolism. There was an improvement in the 5-year survival rate for patients with colorectal cancer, pseudomyxoma peritonei and mesothelioma.

    Conclusion: Our findings demonstrate a learning curve associated with the combined approach of CRS and PIC. With adequate experience, CRS and PIC can be safely performed with acceptable mortality and morbidity.

    © 2015 Royal Australasian College of Surgeons.

  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia. N. Alzahrani, J.S. Ferguson, S.J. Valle, et al. 2016;86(11):937-941. PubMed · Publisher

    Abstract

    Background: Peritoneal carcinomatosis (PC) results from the secondary spread of many intraabdominal tumour types, such as colorectal malignancy (colorectal cancer, CRC), disseminated peritoneal adenomucinosis (DPAM), appendiceal cancer, ovarian carcinoma, sarcoma or from the occurrence of primary peritoneal disease such as peritoneal mesothelioma. The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has seen improvements in survival in selected cases of these cancers.

    Methods: Between 1996 and 2014, a prospective database of 675 patients was created for the peritonectomy unit at our hospital. In total, 827 peritonectomy procedures (including redo CRS) were performed for the major subgroups of PC: DPAM 220; appendiceal cancer (peritoneal mucinous adenocarcinoma (PMCA)) 191; CRC 234; diffuse malignant peritoneal mesothelioma (DMPM) 73 and others 109. There were 152 redo-peritonectomy procedures within the total mentioned earlier (CRC 26; DPAM 58; DMPM 18; appendix 40; other 10).

    Results: The 5-year survivals for DPAM and PMCA were 80% and 42% respectively. The 5-year survivals for appendiceal cancer with peritoneal cancer index (PCI) <10, 10-20 and >20 were 60, 57 and 37% respectively (P = 0.09). The 2- and 5-year survivals for CRC were 56 and 24% respectively. The 5-year survivals for PCI 0-5, 6-10, 11-15 and >15 were 59, 15, 7 and 0% respectively (P = 0.000). The 5-year survival for DMPM with PCI < 10, 10-20 and >20 were 100, 55 and 39% respectively (P = 0.01).

    Conclusion: CRS in combination with HIPEC provides a chance of long-term survival in selected cases of PC when compared with systemic therapy alone.

    © 2015 Royal Australasian College of Surgeons.

  • A case of peritoneal mesothelioma masquerading as a urachal mass. K. Huynh, J. Krantz, N. Ahmadi, et al. 2014;84(3):185-6. Case report PubMed · Publisher

  • Benign multicystic mesothelioma. P. Hollington. 2010;80(3):186-7. Case report PubMed · Publisher

  • Floor of mouth and tongue metastasis from malignant pleural mesothelioma. D. Kirke, K. Horwood, B. Wallwork. 2010;80(7-8):556-8. Case report PubMed · Publisher

    Summary

    The authors, from an ear, nose and throat surgery department in Brisbane, Australia, described a 71-year-old man whose malignant pleural mesothelioma had spread to the floor of the mouth and tongue. He had had significant asbestos exposure in his working life, and mesothelioma had been diagnosed one year earlier. He presented with a right floor of mouth lesion that had been present for 3 weeks and was rapidly enlarging, together with a growing mass in the right neck. MRI showed a tongue mass measuring 5.4 × 4.3 × 3.6 cm that crossed the lingual septum, with lymph node enlargement on both sides of the neck. Chest CT showed no progression of the mesothelioma in the left hemithorax, and abdominal CT was normal. The initial biopsy was thought most likely to show poorly differentiated squamous cell carcinoma. The immunohistochemical profile was consistent with either that cancer or mesothelioma. A multidisciplinary clinic recommended surgery for palliation. The patient had a right hemiglossectomy, a modified radical neck dissection and a tracheostomy. The surgical specimen confirmed metastatic mesothelioma in the tongue, the floor of the mouth and 6 of 21 lymph nodes. Around day 13 after surgery, lesions were found in the liver and pancreas and a new neck mass appeared. He developed aspiration pneumonia and died 6 days later. The authors identified seven earlier reports of this kind. They concluded that accurate histological diagnosis can be difficult. They advised that a new cancer in a patient with known mesothelioma should be presumed to be mesothelioma unless proven otherwise.

    PubMed has no abstract for this study, and the article doesn't print one. We wrote this summary from the full article with the help of AI. It is not the authors' wording.

2000s

  • Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma?. M. Bilgin, L. Hasdiraz, M. Ozkaya, et al. 2007;77(4):253-5. PubMed · Publisher

    Abstract

    Background: As pleurodesis causes systemic inflammation and is associated with considerable cost and morbidity during long-term follow up, the identification of patients who will experience an unsuccessful pleurodesis would be desirable. This study was aimed to investigate whether systemic inflammatory reaction induced by insuflation of talc into the pleura can predict the outcome of pleurodesis.

    Methods: A total of 58 consecutive patients (26 men, 32 women) with malignant pleural mesothelioma underwent video-assisted thoracoscopy under general anaesthesia with monopulmonary ventilation between the years 2003 and 2006. Four grammes of asbestos-free and sterile talc were insuflated into the pleural space under direct vision. To assess the success of pleurodesis, chest radiographs were obtained at the 8th and 30th postoperative days. Venous blood samples were drawn both on admission and at the 24th hour after pleurodesis for the analysis of white blood cells, erythrocyte sedimentation rate and C-reactive protein.

    Results: The mean age (standard deviation) of patients was 59.0 +/- 12.0 years. Pleurodesis was achieved (no effusion on chest radiograph) in 43 of 58 patients (74.1%)(group I), whereas it was unsuccessful in the remaining 15 patients (25.9%)(group II). There was a significant difference between two groups for basal and postpleurodesis levels of measured inflammatory parameters, C-reactive protein and erythrocyte sedimentation rate (for each, P < 0.05). However, the difference was not significant for white blood cells between the groups.

    Conclusion: Serum levels of inflammatory parameters (C-reactive protein and erythrocyte sedimentation rate) may be used to predict the success of pleurodesis in patients with malign mesothelioma who underwent thoracoscopic talc poudrage.

  • Aggressive multimodality treatment for primary malignant peritoneal mesothelioma. W.C. Teoh, K.S. Haghighi, D.L. Morris. 2001;71(11):683-5. Case report PubMed · Publisher

Browse every journal in the library or the library by type of article, or return to medical research.

Cite this page

“ANZ Journal of Surgery.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/journals/anz-journal-of-surgery.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.